e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Monitoring airway diseases with lung function tests
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Do obese asthmatics have a worse bronchodilator response?
Hang Siang Wong (Singapore, Singapore), Hang Siang Wong, Hwee Lee Ng, Corrine Kang, Ying Juan Mok, Xue Ning Choo
Source:
International Congress 2015 – Monitoring airway diseases with lung function tests
Session:
Monitoring airway diseases with lung function tests
Session type:
Thematic Poster Session
Number:
1036
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Hang Siang Wong (Singapore, Singapore), Hang Siang Wong, Hwee Lee Ng, Corrine Kang, Ying Juan Mok, Xue Ning Choo. Do obese asthmatics have a worse bronchodilator response?. Eur Respir J 2015; 46: Suppl. 59, 1036
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Response to bronchodilators in school children with asthma and normal FEV1
Source: International Congress 2016 – Living with asthma around the globe
Year: 2016
Bronchodilators in school children with asthma and normal FEV1
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
Airway resistances deteriorate following spirometry in asthma and COPD patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Efficacy of tiotropium Respimat® in adults with moderate asthma, by baseline LTRA use
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Tiotropium as add-on to inhaled corticosteroids significantly improves asthma control as reflected by the ACQ responder rate
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013
Evaluating the effects of inhaled corticosteroid on insulin sensitivity in asthmatic patients
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Pulmonary response to salbutamol inhalation using dynamic OE-MRI in patients with asthma
Source: Annual Congress 2013 –The different modalities for current imaging and for future issues
Year: 2013
Bronchial hyperresponsiveness as a predictor of treatment-response in COPD
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Lung function and safety
Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD
Year: 2013
Effect of breathing parameters on lung dose in case of two combination drugs used in asthma and COPD therapy
Source: International Congress 2016 – Pulmonary drug delivery
Year: 2016
B2-adrenoceptor genotype16 influences airway calibre but not hyperresponsiveness in asthmatics using regular B2-agonist in addition to inhaled corticosteroids
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013
Dysphonia in asthmatic women using inhaled corticosteroids: It is not only a laryngeal inflammation
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
Predictors of good inhaler technique in asthma and COPD
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
The effect of smoking cessation on methacholine responsiveness in young asthma patients
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
Airway hyperresponsiveness in patients treated with omalizumab
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
The parameters that may affect inhalation therapy success in elderly COPD and asthma patients
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
Bronchodilator reversibility (BDR) - should we measure it in adults with symptoms but without obstructed spirometry?
Source: Virtual Congress 2021 – Primary care diagnosis and multimorbidities
Year: 2021
Bronchodilators in school children with asthma and normal FEV1
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
Induced sputum cytology and pulmonary function tests in ex-smoker asthmatic patients controlled with inhaled steroid and long acting beta agonist therapy
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015
Assessing bronchodilator response (BDR) in preschool children using spirometry
Source: International Congress 2014 – Paediatric asthma: lung function testing and more
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept